CRISPR Therapeutics AG (CRSP) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2015: $124.03M2016: $112.12M2017: $83.51M2018: $96.82M2019: $127.33M2020: $163.73M2021: $352.42M2022: $367.58M2023: $346.77M2024: $309.95M2025: $343.43M$343.43M
2015Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$343.43M+10.8%
2024$309.95M-10.6%
2023$346.77M-5.7%
2022$367.58M+4.3%
2021$352.42M+115.2%
2020$163.73M+28.6%
2019$127.33M+31.5%
2018$96.82M+15.9%
2017$83.51M-25.5%
2016$112.12M-9.6%
2015$124.03M